1. Brainstem Low-Grade Gliomas in Children—Excellent Outcomes With Multimodality Therapy. (February 2017) Authors: Upadhyaya, Santhosh A.; Koschmann, Carl; Muraszko, Karin; Venneti, Sriram; Garton, Hugh J.; Hamstra, Daniel A.; Maher, Cormac O.; Betz, Bryan L.; Brown, Noah A.; Wahl, Daniel; Weigelin, Helmut C.; DuRoss, Kathleen E.; Leonard, Annette S.; Robertson, Patricia L. Journal: Journal of child neurology Issue: Volume 32:Number 2(2017:Feb.) Page Start: 194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CTNI-15. PHASE 0/I TRIAL OF MYCOPHENOLATE MOFETIL COMBINED WITH RADIATION TO OVERCOME GLIOBLASTOMA TREATMENT RESISTANCE BY TARGETING DE-NOVO PURINE METABOLISM: INTERIM REPORT. (12th November 2021) Authors: Umemura, Yoshie; Sun, Yilun; Junck, Larry; Leung, Denise; Kim, Michelle; Al-Holou, Wajd; Sagher, Oren; Heth, Jason; Schipper, Matthew; Lyssiotis, Costas; Marini, Bernard; Lawrence, Theodore; Wahl, Daniel Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CTNI-35. PHASE 0/1 TRIAL OF MYCOPHENOLATE MOFETIL COMBINED WITH CHEMORADIATION TO OVERCOME TREATMENT RESISTANCE IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA BY TARGETING PURINE METABOLISM. (14th November 2022) Authors: Umemura, Yoshie; Al-Holou, Wajd; Marini, Bernard; Leung, Denise; Kim, Michelle; Ferris, Sean; Junck, Larry; Sagher, Oren; Heth, Jason; Sun, Yilun; Schipper, Matthew; Lyssiotis, Costas; Lawrence, Theodore; Wahl, Daniel Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DDRE-19. PHASE 0/I TRIAL OF MYCOPHENOLATE MOFETIL COMBINED WITH RADIATION TO OVERCOME GLIOBLASTOMA TREATMENT RESISTANCE BY TARGETING DE-NOVO PURINE METABOLISM. (25th March 2021) Authors: Umemura, Yoshie; Sun, Yilun; Junck, Larry; Leung, Denise; Kim, Michelle; Al-Holou, Wajd; Sagher, Oren; Heth, Jason; Lyssiotis, Costas; Marini, Bernard; Lawrence, Theodore; Wahl, Daniel Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 1 Page Start: i10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DDRE-24. TARGETING PURINE METABOLISM TO OVERCOME GLIOBLASTOMA THERAPY RESISTANCE. (25th March 2021) Authors: Zhou, Weihua; Yao, Yangyang; Scott, Andrew; Wilder-Romans, Kari; Dresser, Joseph; Werner, Christian; Sun, Hanshi; Pratt, Drew; Sajjakulnukit, Peter; Zaho, Shuang; Davis, Mary; Nelson, Barbara; Halbrook, Christopher; Zhang, Li; Gatto, Francesco; Srinivasan, Sudharsan; Jairath, Neil; Correa, Luis; ... Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 1 Page Start: i11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DDRE-28. MECHANISTIC AND THERAPEUTIC LINKS BETWEEN PURINE BIOSYNTHESIS AND DNA DAMAGE IN GLIOBLASTOMA. (25th March 2021) Authors: Scott, Andrew; Zhou, Weihua; Wilder-Romans, Kari; Feng, Jiane; Wu, Zhe; Andren, Anthony; Zhang, Li; Sajjakulnukit, Peter; Kachman, Maureen; Umemura, Yoshie; Schmitt, Melanie; Qi, Nathan; Lawrence, Theodore; Lyssiotis, Costas; Wahl, Daniel Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 1 Page Start: i12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EXTH-15. TARGETING ANDROGEN SIGNALING IN GLIOBLASTOMA (GBM) USING SEVITERONEL (SEVI), A CYP17 LYASE AND ANDROGEN RECEPTOR (AR) INHIBITOR, ALONE AND IN COMBINATION WITH RADIATION (RT). (5th November 2018) Authors: Sun, Hanshi; Werner, Christian; Dresser, Joseph; Wilder-Romans, Kari; Baskin-Bey, Edwina; Eisner, Joel; Lawrence, Theodore; Spratt, Daniel; Speers, Corey; Wahl, Daniel Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. EXTH-27. MOLECULAR CHARACTERIZATION AND PRECLINICAL DEVELOPMENT OF NOVEL SMALL MOLECULE INHIBITOR SPECIFIC FOR WILD-TYPE IDH1 FOR FERROPTOSIS INDUCTION IN GLIOBLASTOMA. (12th November 2021) Authors: Murnan, Kevin; Tommasini-Ghelfi, Serena; Hurley, Lisa; Dussold, Corey; Wahl, Daniel; Stegh, Alexander Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. LMD-09. Outcomes and symptom benefit from palliative radiotherapy for leptomeningeal disease in breast cancer patients. (9th August 2021) Authors: Takayesu, Jamie; Sapir, Eli; Xie, Jiaheng; Sun, Yilun; Morikawa, Aki; Junck, Larry; Leung, Denise; Umemura, Yoshie; Heth, Jason; Al-Holou, Wajd; Wahl, Daniel; Lawrence, Theodore; Mayo, Charles; Hayman, James; Kim, Michelle Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 3 Page Start: iii9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Localization and functional characterization of the p.Asn965Ser (N965S) ABCA4 variant in mice reveal pathogenic mechanisms underlying Stargardt macular degeneration. (14th November 2017) Authors: Molday, Laurie L; Wahl, Daniel; Sarunic, Marinko V; Molday, Robert S Journal: Human molecular genetics Issue: Volume 27:Number 2(2018:Jan. 15) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗